BioGaia Inks Agreement With Ferring Pharma In Argentina

BioGaia has entered into an agreement with Ferring Pharmaceuticals in Argentina. The agreement refers to sales of BioGaia Probiotic drops and tablets under the BioGaia brand. Launch is estimated durin...

Published: 19-Mar-2010

4-Antibody Collaborates With Boehringer Ingelheim For Antibody Discovery

4-Antibody, a Swiss Biotech company active in the area of therapeutic antibody drug development, has entered into a long-term collaboration with Boehringer Ingelheim to discover and develop fully huma...

Published: 16-Mar-2010

Microbide, LBR Regulatory Sign Agreement To Develop Topical Solutions

Microbide and LBR Regulatory & Clinical Consulting Services (LBR Regulatory) have entered into an agreement for LBR Regulatory to assess the potential for development of topical solutions to address f...

Published: 16-Mar-2010

LLS, Forma Join To Develop Anti-cancer Therapies

Leukemia & Lymphoma Society (LLS) and Forma Therapeutics have entered into a partnership to discover and develop novel therapies for cancer patients with diffuse large B cell lymphoma. The companies a...

Published: 15-Mar-2010

Manhattan Pharma Merges With Ariston Pharma

Manhattan Pharmaceuticals (Manhattan) has entered into a definitive agreement and plan of merger and completed the merger transaction with Ariston Pharmaceuticals. As a result of the merger, Ariston b...

Published: 15-Mar-2010

Achillion Pharma Q4 Net Loss Shrinks

Achillion Pharma has reported a net loss of $6.7m for the fourth quarter ended December 31, 2009, or $0.25 per diluted share, compared to $8.69m, or $0.33 per diluted share, for the comparable period ...

Published: 15-Mar-2010

Rexahn Pharma Gets Japanese Patent For Archexin

Rexahn Pharma has been issued a Japanese patent for its anti-cancer compound Archexin, which is currently undergoing Phase II clinical trial for the treatment of pancreatic cancer. ...

Published: 12-Mar-2010

Caraco Pharma Launches Oxaliplatin Injections

Caraco Pharmaceutical Laboratories, a subsidiary of Sun Pharma and a developer and distributer of generic pharmaceuticals, has launched 50mg and 100mg oxaliplatin injections for the treatment of colon...

Published: 11-Mar-2010

Dainippon Sumitomo Pharma America Gets FDA Nod For Lurasidone

Dainippon Sumitomo Pharma America, a US subsidiary of Dainippon Sumitomo Pharma (DSP), has reported that the FDA has accepted for review the lurasidone new drug application (NDA) for the treatment of ...

Published: 11-Mar-2010

Salix Pharma Q4 Net Loss Narrows

Salix Pharma has reported a net loss of $7.02m, or $0.13 per diluted share, for the fourth quarter ended December 31, 2009, compared to $11.07m, or $0.23 per diluted share, for the comparable period i...

Published: 10-Mar-2010

more news...